MOONLAKE IMMUNOTHERAPEUTICS

Insiders MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq Other stock markets 21:00:00 22/05/2024 BST			5-day change	1st Jan Change
39.91 ^USD	+2.25%		-1.92%	-33.91%

05-07	MoonLake Immunotherapeutics Q1 Net Loss Widens	MT
05-07	MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Moonlake Immunotherapeutics Insider Sold Shares Worth $6,803,044, According to a Recent SEC Filing	03-01	MT
Moonlake Immunotherapeutics Insider Sold Shares Worth $6,540,710, According to a Recent SEC Filing	03-01	MT
Moonlake Immunotherapeutics Insider Sold Shares Worth $1,208,418, According to a Recent SEC Filing	02-23	MT
Moonlake Immunotherapeutics Insider Sold Shares Worth $5,917,368, According to a Recent SEC Filing	12-21	MT
Moonlake Immunotherapeutics Insider Bought Shares Worth $3,524,297, According to a Recent SEC Filing	10/10/23	MT
Moonlake Immunotherapeutics Insider Bought Shares Worth $16,800,343, According to a Recent SEC Filing	04/10/23	MT
Insider Buy: MoonLake Immunotherapeutics	29/06/23	MT
Insider Buy: MoonLake Immunotherapeutics	22/03/23	MT
Insider Buy: MoonLake Immunotherapeutics	08/04/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer